Heron Therapeutics (NASDAQ:HRTX) Downgraded to Hold Rating by StockNews.com
StockNews.com downgraded shares of Heron Therapeutics (NASDAQ:HRTX – Free Report) from a buy rating to a hold rating in a research note issued to investors on Thursday. Separately, Needham & Company LLC restated a “buy” rating and issued a $4.00 target price on shares of Heron Therapeutics in a report on Wednesday, December 4th. Check […]
More Stories
SigmaTron International (NASDAQ:SGMA) Releases Quarterly Earnings Results
SigmaTron International (NASDAQ:SGMA – Get Free Report) released its quarterly earnings results on Friday. The technology company reported ($1.55) earnings...
Sudan’s El Fasher siege: UN humanitarians killed as refugee crisis intensifies
The ongoing conflict in Sudan - particularly around besieged El Fasher – and a growing refugee crisis on the South...
Severin Hacker Sells 10,000 Shares of Duolingo, Inc. (NASDAQ:DUOL) Stock
Duolingo, Inc. (NASDAQ:DUOL – Get Free Report) insider Severin Hacker sold 10,000 shares of the business’s stock in a transaction...
Royal Helium (CVE:RHC) Shares Down 16.7% – Here’s What Happened
Royal Helium Ltd. (CVE:RHC – Get Free Report) fell 16.7% during mid-day trading on Friday . The company traded as...
Boston Beer (NYSE:SAM) Issues FY 2024 Earnings Guidance
Boston Beer (NYSE:SAM – Get Free Report) updated its FY 2024 earnings guidance on Friday. The company provided EPS guidance...
SharkNinja (NYSE:SN) Shares Down 4.7% – What’s Next?
SharkNinja, Inc. (NYSE:SN – Get Free Report) fell 4.7% during mid-day trading on Wednesday . The company traded as low...